Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRDL NYSE:DNA NYSE:NVO NASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRDLCardiol Therapeutics$1.20+0.4%$1.30$0.77▼$2.63$100.42M1.04310,365 shs158,597 shsDNAGinkgo Bioworks$11.30+11.5%$8.94$5.00▼$16.85$667.83M1.481.43 million shs2.03 million shsNVONovo Nordisk A/S$64.96+1.0%$70.34$57.00▼$139.74$290.01B0.647.38 million shs7.01 million shsTLRYTilray Brands$0.67+8.2%$0.46$0.35▼$2.15$676.37M1.8231.36 million shs37.27 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRDLCardiol Therapeutics0.00%-7.75%-4.03%+22.68%-43.06%DNAGinkgo Bioworks0.00%+1.50%+18.72%+37.82%-24.24%NVONovo Nordisk A/S0.00%-6.69%-12.80%+10.19%-51.10%TLRYTilray Brands0.00%+7.03%+72.58%+38.81%-65.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRDLCardiol Therapeutics2.3705 of 5 stars3.73.00.00.02.30.00.6DNAGinkgo Bioworks0.8911 of 5 stars1.01.00.00.02.52.51.3NVONovo Nordisk A/S4.234 of 5 stars3.14.02.50.03.40.03.1TLRYTilray Brands1.7048 of 5 stars3.11.00.00.02.50.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRDLCardiol Therapeutics 3.33Buy$8.00569.46% UpsideDNAGinkgo Bioworks 2.00Hold$8.50-24.76% DownsideNVONovo Nordisk A/S 2.27Hold$112.0072.41% UpsideTLRYTilray Brands 2.25Hold$1.92185.22% UpsideCurrent Analyst Ratings BreakdownLatest CRDL, NVO, TLRY, and DNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025CRDLCardiol TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$9.004/28/2025NVONovo Nordisk A/SHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/25/2025NVONovo Nordisk A/SDbs BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeSell(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRDLCardiol TherapeuticsN/AN/AN/AN/A$0.22 per shareN/ADNAGinkgo Bioworks$227.04M2.91N/AN/A$13.17 per share0.86NVONovo Nordisk A/S$42.12B6.89$3.94 per share16.49$4.66 per share13.94TLRYTilray Brands$788.94M0.86N/AN/A$4.14 per share0.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRDLCardiol Therapeutics-$26.77M-$0.34N/AN/AN/AN/A-209.63%-141.09%8/11/2025 (Estimated)DNAGinkgo Bioworks-$547.03M-$9.16N/AN/AN/A-198.84%-52.35%-27.14%8/14/2025 (Estimated)NVONovo Nordisk A/S$14.64B$3.3819.2213.941.2434.52%80.94%24.23%8/6/2025 (Estimated)TLRYTilray Brands-$244.98M-$1.05N/AN/AN/A-113.85%-7.40%-6.02%7/28/2025 (Estimated)Latest CRDL, NVO, TLRY, and DNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025DNAGinkgo Bioworks-$1.44N/AN/AN/AN/AN/A8/11/2025Q2 2025CRDLCardiol Therapeutics-$0.11N/AN/AN/AN/AN/A8/6/2025Q2 2025 NVONovo Nordisk A/S$0.89N/AN/AN/A$77.51 billionN/A7/28/2025Q4 2025TLRYTilray Brands-$0.03N/AN/AN/A$250.41 millionN/A5/7/2025Q1 2025NVONovo Nordisk A/S$0.92$0.92N/A$0.92N/A$11.87 billion5/6/2025Q1 2025DNAGinkgo Bioworks-$1.23-$1.58-$0.35-$1.68$38.70 million$48.32 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRDLCardiol TherapeuticsN/AN/AN/AN/AN/ADNAGinkgo BioworksN/AN/AN/AN/AN/ANVONovo Nordisk A/S$1.642.52%N/A48.52%N/ATLRYTilray BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRDLCardiol Therapeutics0.013.263.26DNAGinkgo BioworksN/A4.884.88NVONovo Nordisk A/S0.700.740.56TLRYTilray Brands0.122.621.61Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRDLCardiol Therapeutics12.49%DNAGinkgo Bioworks78.63%NVONovo Nordisk A/S11.54%TLRYTilray Brands9.35%Insider OwnershipCompanyInsider OwnershipCRDLCardiol Therapeutics5.25%DNAGinkgo Bioworks9.72%NVONovo Nordisk A/S0.07%TLRYTilray Brands0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRDLCardiol Therapeutics2082.65 million78.31 millionNot OptionableDNAGinkgo Bioworks64058.53 million52.84 millionOptionableNVONovo Nordisk A/S77,3494.47 billion4.46 billionOptionableTLRYTilray Brands2,6501.01 billion1.00 billionOptionableCRDL, NVO, TLRY, and DNA HeadlinesRecent News About These CompaniesTilray Brands (TLRY) Projected to Post Quarterly Earnings on MondayJuly 21 at 4:34 AM | marketbeat.comTop Canadian Cannabis Picks for U.S. Market Expansion in 2025July 19 at 10:00 AM | marijuanastocks.comMMarketBeat Week in Review – 07/14 - 07/18 (TLRY)...July 19 at 7:00 AM | marketbeat.comTilray Brands (NASDAQ:TLRY) Trading Up 3.2% - Here's What HappenedJuly 18 at 1:42 PM | marketbeat.comTilray Brands, Inc. (TLRY) Beats Stock Market Upswing: What Investors Need to KnowJuly 17, 2025 | zacks.comTilray Brands (NASDAQ:TLRY) Trading Up 4% - Should You Buy?July 17, 2025 | marketbeat.comTilray (TLRY) Stock Is Up, What You Need To KnowJuly 16, 2025 | msn.comTilray Brands (NASDAQ:TLRY) Shares Up 4% - What's Next?July 16, 2025 | marketbeat.comTilray Brands (NasdaqGS:TLRY) Soars 44% In Last MonthJuly 15, 2025 | finance.yahoo.comTilray (TLRY) Shares Skyrocket, What You Need To KnowJuly 15, 2025 | msn.comTilray Brands (NASDAQ:TLRY) Trading Down 6.2% - What's Next?July 15, 2025 | marketbeat.comTilray Brands stock price is surging: time to buy or sell?July 15, 2025 | invezz.comITilray Brands stock price is surging: time to buy or sell?July 15, 2025 | invezz.comIUp Around 40% in Just the Past Month, Could This Red-Hot Growth Stock Rally Even Higher?July 15, 2025 | fool.comTilray Shares Blazing: What's Behind the 55% Rally This Month?...July 14, 2025 | marketbeat.comTilray Brands (NASDAQ:TLRY) Stock Price Up 7% - Here's What HappenedJuly 14, 2025 | marketbeat.comTilray Brands, Inc. (TLRY) Declines More Than Market: Some Information ...July 13, 2025 | finance.yahoo.comCannabis Stocks To Follow Today - July 13thJuly 13, 2025 | marketbeat.comPromising Cannabis Stocks To Follow Now - July 12thJuly 12, 2025 | marketbeat.comTilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for InvestorsJuly 11, 2025 | zacks.comTop Cannabis Stocks To Watch Today - July 11thJuly 11, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI SpendingTilray Shares Blazing: What's Behind the 55% Rally This Month?By Nathan Reiff | July 14, 2025View Tilray Shares Blazing: What's Behind the 55% Rally This Month?CRDL, NVO, TLRY, and DNA Company DescriptionsCardiol Therapeutics NASDAQ:CRDL$1.20 +0.01 (+0.42%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.Ginkgo Bioworks NYSE:DNA$11.30 +1.17 (+11.52%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.Novo Nordisk A/S NYSE:NVO$64.96 +0.65 (+1.02%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.Tilray Brands NASDAQ:TLRY$0.67 +0.05 (+8.16%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analysts See Upside in These 5 Stocks That Just Raised Dividends MarketBeat Week in Review – 07/14 - 07/18 Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For Kinder Morgan: At the Hotspot of the Natural Gas Revolution Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
